1. Home
  2. VYNE vs DUOT Comparison

VYNE vs DUOT Comparison

Compare VYNE & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • DUOT
  • Stock Information
  • Founded
  • VYNE 2003
  • DUOT 1990
  • Country
  • VYNE United States
  • DUOT United States
  • Employees
  • VYNE N/A
  • DUOT N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • VYNE Health Care
  • DUOT Technology
  • Exchange
  • VYNE Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • VYNE 41.9M
  • DUOT 34.8M
  • IPO Year
  • VYNE 2018
  • DUOT N/A
  • Fundamental
  • Price
  • VYNE $2.49
  • DUOT $5.70
  • Analyst Decision
  • VYNE Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • VYNE 2
  • DUOT 2
  • Target Price
  • VYNE $6.88
  • DUOT $8.75
  • AVG Volume (30 Days)
  • VYNE 70.8K
  • DUOT 114.1K
  • Earning Date
  • VYNE 11-07-2024
  • DUOT 11-19-2024
  • Dividend Yield
  • VYNE N/A
  • DUOT N/A
  • EPS Growth
  • VYNE N/A
  • DUOT N/A
  • EPS
  • VYNE N/A
  • DUOT N/A
  • Revenue
  • VYNE $493,000.00
  • DUOT $7,346,014.00
  • Revenue This Year
  • VYNE $28.30
  • DUOT $33.94
  • Revenue Next Year
  • VYNE N/A
  • DUOT $147.69
  • P/E Ratio
  • VYNE N/A
  • DUOT N/A
  • Revenue Growth
  • VYNE 39.27
  • DUOT N/A
  • 52 Week Low
  • VYNE $1.57
  • DUOT $1.94
  • 52 Week High
  • VYNE $3.43
  • DUOT $6.44
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 40.82
  • DUOT 63.28
  • Support Level
  • VYNE $2.34
  • DUOT $4.35
  • Resistance Level
  • VYNE $2.69
  • DUOT $4.89
  • Average True Range (ATR)
  • VYNE 0.19
  • DUOT 0.53
  • MACD
  • VYNE -0.04
  • DUOT -0.00
  • Stochastic Oscillator
  • VYNE 13.79
  • DUOT 94.57

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: